Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
AG
agilon health, inc.
AGL
Mkt Cap
$1.43B
Volume
96.69K
Next Earnings
November 3rd
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
AG
AGL
AG
agilon health, inc.
AGL
News
·
Global Value-Based Healthcare Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight
Mkt Cap
$1.43B
Volume
96.69K
Next Earnings
November 3rd
Chart
Financials
Earnings
News
About
Insider
Filings
Global Value-Based Healthcare Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight
The value-based healthcare market is experiencing robust growth, projected to reach USD 62 billion by 2034 from USD 16.5 billion in 2025, with a CAGR of ~16%. The shift from fee-for-service to outcome-based payment models is driven by rising healthcare costs, chronic disease burden, and government reimbursement reforms. North America dominates with 72% market share, while Asia-Pacific is expected to record the fastest growth. Key players include Optum, Humana, Evolent Health, Agilon Health, and Privia Health.
GlobeNewswire Inc. · Sep 16, 2026
These ETFs Owned Russell 2000's Biggest Winners Before They Soared 400%+ In 2026
Several Russell 2000 small-cap stocks have surged 400%+ in 2026, driven by AI infrastructure demand. Companies like Applied Optoelectronics, Aehr Test Systems, and MaxLinear—which supply optical networking, semiconductor testing, and connectivity products—have outperformed mega-cap tech stocks. Small-cap growth ETFs including VTWG, IWO, and ISMD provided early exposure to these winners before they became mainstream AI investment stories.
Benzinga · Jun 3, 2026
Micron And Dell Are Up 260%: These 5 Small Caps Nearly Doubled That
While Micron and Dell have surged 260% in 2026 driven by AI server demand, five Russell 2000 small-cap stocks have each rallied over 400%. Four are AI supply chain plays (optical components, semiconductor testing, networking chips), while one is an unrelated healthcare company. Applied Optoelectronics leads at +473%, followed by Rackspace at +461%, Aehr Test Systems at +436%, agilon health at +404%, and MaxLinear at +398%.
Benzinga · Jun 2, 2026
7 Small-Cap Stocks More Than Doubled In May: Micron Did Only 46%
Seven Russell 2000 small-cap stocks more than doubled in May 2026, significantly outperforming Micron Technology's 46% gain. The rallies were driven by specific catalysts including strong earnings reports, guidance raises, strategic partnerships, and defense contracts. Hyliion Holdings led with a 213.6% gain, followed by Agilon Health at 209.1%, with each company benefiting from positive business developments and analyst upgrades.
Benzinga · May 25, 2026
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 2, 2026 in agilon health, inc. Lawsuit – AGL
Law firm Levi & Korsinsky notifies investors of class action securities lawsuits against agilon health, inc., Ardent Health, Inc., and Zynex, Inc. The primary case involves agilon health for alleged securities fraud between February 26, 2025 and August 4, 2025, with claims that defendants issued false 2025 guidance and overstated financial impacts from strategic actions. Lead plaintiff deadlines range from March 2 to April 21, 2026.
GlobeNewswire Inc. · Mar 2, 2026
DEADLINE ALERT for AGL, FRMI, VRNS, and ARDT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz has announced class action lawsuits against four publicly-traded companies for allegedly making materially false and misleading statements to investors. Agilon Health is accused of issuing unachievable 2025 guidance; Fermi Inc. of overstating tenant demand for Project Matador; Varonis Systems of failing to disclose growth trajectory challenges; and Ardent Health of misrepresenting accounts receivable practices and insurance coverage. Lead plaintiff deadlines range from March 2-9, 2026.
GlobeNewswire Inc. · Mar 2, 2026
AGILON CLASS ACTION DEADLINE MARCH 2nd: Bragar Eagel & Squire, P.C. Urgently Reminds Agilon Health Investors with Large Losses to Contact the Firm Before the Lead Plaintiff Deadline
A class action lawsuit has been filed against Agilon Health, Inc. (NYSE: AGL) for allegedly making false and misleading statements regarding 2025 guidance and overstating financial impacts from strategic actions. Investors who purchased Agilon securities between February 26, 2025 and August 4, 2025 have until March 2, 2026 to apply as lead plaintiff.
GlobeNewswire Inc. · Mar 1, 2026
Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm
A class action lawsuit has been filed against agilon health, inc. alleging that company executives made false and misleading statements regarding 2026 guidance and overstated the financial impact of strategic risk reduction actions during the period from February 26, 2025 to August 4, 2025. Investors who purchased agilon securities during this period are encouraged to join the case, with a lead plaintiff deadline of March 2, 2026.
GlobeNewswire Inc. · Feb 27, 2026
AGILON DEADLINE MARCH 2nd: Bragar Eagel & Squire, P.C. Urgently Reminds Agilon Health Investors with Larges Losses to Contact the Firm Before the Lead Plaintiff Deadline
A class action lawsuit has been filed against Agilon Health, Inc. for allegedly making false and misleading statements regarding 2025 guidance and overstating financial impacts from strategic actions. Investors who purchased Agilon securities between February 26, 2025 and August 4, 2025 have until March 2, 2026 to apply as lead plaintiff.
GlobeNewswire Inc. · Feb 24, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in agilon health, inc. of Class Action Lawsuit and Upcoming Deadlines - AGL
Pomerantz Law Firm has filed class action lawsuits against agilon health, inc. and other companies for alleged securities fraud. Agilon's CEO stepped down on August 4, 2025, and the company suspended its 2025 financial guidance, citing acute industry headwinds. The stock fell 51.52% to $0.88 per share on August 5, 2025. Investors have until March 2, 2026 to request Lead Plaintiff status.
GlobeNewswire Inc. · Feb 24, 2026
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
AG
AGL
agilon health, inc.
Buy
Sell
Market
Limit
Soon
AGL
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any AGL yet.
Related Tickers
Earnings